author-photo

Kurtis R. Bray

Beckman Coulter

13

Papers

693

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Diagnostic performance of cardiac Troponin I for early rule-in and rule-out of acute myocardial infarction: Results of a prospective multicenter trial☆

2015 Clinical Biochemistry
Show All
- Source
- Cite
- Save
Citations (22)
Registering Diagnostic and Prognostic Trials of Tests: Is it the Right Thing to Do?

2014 Clinical Chemistry
Show All
- Source
- Cite
- Save
Citations (18)
Abstract 12104: Absolute and Relative Changes (Delta) in Troponin I for Early Diagnosis of Myocardial Infarction: Results of a Prospective Multicenter Trial

2014 Circulation
Show All
- Source
- Cite
- Save
Citations (2)
Immune monitoring with iTAg MHC Tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter study

2010 Blood
Show All
- Source
- Cite
- Save
Citations (98)
Immune Monitoring with iTAg™ MHC Tetramers*: Potential Clinical Utility in the Prediction of Recurrent CMV Reactivation in Allogeneic Stem Cell Transplant Recipients

2004 Journal of Immunotherapy
Show All
- Source
- Cite
- Save
Citations (0)
Analytical performance and reproducibility of Beckman Coulters iTAgTM MHC tetramers* in measurement of antigen specific T cells in blood

2003 Clinical Chemistry
Show All
- Source
- Cite
- Save
Citations (3)
Hybritech total and free prostate-specific antigen assays developed for the Beckman Coulter access automated chemiluminescent immunoassay system: a multicenter evaluation of analytical performance.

2001 Clinical Chemistry
Show All
- Source
- Cite
- Save
Citations (28)
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging.

2000 Urology
Show All
- Source
- Cite
- Save
Citations (290)
Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine the clinical utility of percentage of free prostate-specific antigen

1999 Clinical Chemistry
Show All
- Source
- Cite
- Save
Citations (7)